Skip to content

Cepharanthine

Drug profile

Also known as: cepharanthin

PMDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Cepharanthine is a drug catalogued in DrugCentral. It was first approved by the PMDA in 1951. DrugCentral lists 6 molecular targets, including REP, KCNN3 and KCNN2. Recorded indications include Alopecia, Aptyalism, Leukopenia and Snake bite - wound.

  • Molecular targets: REP, KCNN3, KCNN2 and TPR (6 listed in DrugCentral).
  • Indications: Alopecia, Aptyalism, Leukopenia and Snake bite - wound.
  • Molecular formula: C37H38N2O6; molecular weight 606.72 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (4)

  • Alopecia
  • Aptyalism
  • Leukopenia
  • Snake bite - wound

Off-label uses (1)

  • Coronavirus infection

Mechanism & targets

Molecular targets (6)

TargetGeneActionActivity
Replicase polyprotein 1abREPunknownIC50 7.00
Small conductance calcium-activated potassium channel protein 3KCNN3unknownKi 5.96
Small conductance calcium-activated potassium channel protein 2KCNN2unknownKi 5.88
Trypanothione reductaseTPRunknownKi 5.12
5'-AMP-activated protein kinase catalytic subunit alpha-1PRKAA1inhibitor—
Nuclear factor NF-kappa-B p105 subunitNFKB1inhibitor—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1951-01-01PMDA——

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Cepharanthine is on its molecule page.

Molecular formulaC37H38N2O6
Molecular weight606.72 g/mol
CAS number481-49-2
InChIKeyYVPXVXANRNDGTA-WDYNHAJCSA-N
PubChem CID10206
COC1=C2OC3=CC=C(C[C@@H]4N(C)CCC5=CC6=C(OCO6)C(OC6=C(OC)C=C7CCN(C)[C@H](CC(C=C1)=C2)C7=C6)=C45)C=C3

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Cepharanthine used for?

DrugCentral lists the following indications for Cepharanthine: Alopecia, Aptyalism, Leukopenia and Snake bite - wound.

How does Cepharanthine work?

Its molecular targets in DrugCentral include REP, KCNN3, KCNN2 and TPR.

When was Cepharanthine first approved?

Cepharanthine was first approved by the PMDA in 1951.

What is the chemical formula of Cepharanthine?

Cepharanthine has the molecular formula C37H38N2O6 and a molecular weight of 606.72 g/mol.

Browse: all drugs starting with C · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1951-01-01
AgencyPMDA
Targets6
Indications4
FormulaC37H38N2O6
DrugCentral ID5375
Interactive profile